Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0000950170-24-127992

SVP, Head of Finance & Admin. sold 2,735 shares at $28.20 ($77,127)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Scalzo Richard William SVP, Head of Finance & Admin. 2024-11-18 Sale 10b5-1 −2,735 $28.20 $77,127 95,833 D
Open-market sales · 2,735 sh · avg $28.20 · $77,127
Loading xslF345X05/ownership.xml…